Related references
Note: Only part of the references are listed.Contribution of the immune system to bystander and non-targeted effects of ionizing radiation
Franz Roedel et al.
CANCER LETTERS (2015)
Responses to ionizing radiation mediated by inflammatory mechanisms
Debayan Mukherjee et al.
JOURNAL OF PATHOLOGY (2014)
Regulation of Ligands for the NKG2D Activating Receptor
David H. Raulet et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Molecular Pathways: Radiation-Induced Cognitive Impairment
Dana Greene-Schloesser et al.
CLINICAL CANCER RESEARCH (2013)
Angiotensin-(1-7) prevents radiation-induced inflammation in rat primary astrocytes through regulation of MAP kinase signaling
Elizabeth D. Moore et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Engineered Drug Resistant γδ T Cells Kill Glioblastoma Cell Lines during a Chemotherapy Challenge: A Strategy for Combining Chemo- and Immunotherapy
Lawrence S. Lamb et al.
PLOS ONE (2013)
Astrocytes Directly Influence Tumor Cell Invasion and Metastasis In Vivo
Ling Wang et al.
PLOS ONE (2013)
Adoptive cell therapies for glioblastoma
Kevin Bielamowicz et al.
FRONTIERS IN ONCOLOGY (2013)
Six-of-the-best: unique contributions of γδ T cells to immunology
Pierre Vantourout et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Modulation of Inflammatory Immune Reactions by Low-Dose Ionizing Radiation: Molecular Mechanisms and Clinical Application
F. Roedel et al.
CURRENT MEDICINAL CHEMISTRY (2012)
The Effect of Chemotherapy/Radiotherapy on Cancerous Pattern Recognition by NK Cells
B. Rosental et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Current Concepts and Management of Glioblastoma
Matthias Preusser et al.
ANNALS OF NEUROLOGY (2011)
Major histocompatibility complex class I-related chain A/B (MICA/B) expression in tumor tissue and serum of pancreatic cancer: Role of uric acid accumulation in gemcitabine-induced MICA/B expression
Xiulong Xu et al.
BMC CANCER (2011)
Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours
A. J. Nicol et al.
BRITISH JOURNAL OF CANCER (2011)
Novel Role for STAT3 in Transcriptional Regulation of NK Immune Cell Targeting Receptor MICA on Cancer Cells
Romain Bedel et al.
CANCER RESEARCH (2011)
Preclinical evaluation of ex vivo expanded/activated gamma delta T cells for immunotherapy of glioblastoma multiforme
Nichole L. Bryant et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Cranial Irradiation Leads to Acute and Persistent Neuroinflammation with Delayed Increases in T-Cell Infiltration and CD11c Expression in C57BL/6 Mouse Brain
Michael J. Moravan et al.
RADIATION RESEARCH (2011)
Astrocytes Upregulate Survival Genes in Tumor Cells and Induce Protection from Chemotherapy
Sun-Jin Kim et al.
NEOPLASIA (2011)
Targeting γδ T Lymphocytes for Cancer Immunotherapy: From Novel Mechanistic Insight to Clinical Application
Anita Q. Gomes et al.
CANCER RESEARCH (2010)
Irradiation induces regionally specific alterations in pro-inflammatory environments in rat brain
Won Hee Lee et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2010)
ROLE OF INTERCELLULAR ADHESION MOLECULE-1 IN RADIATION-INDUCED BRAIN INJURY
Kai-Liang Wu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
Richard A. Morgan et al.
MOLECULAR THERAPY (2010)
Irradiation-Induced Up-Regulation of HLA-E on Macrovascular Endothelial Cells Confers Protection against Killing by Activated Natural Killer Cells
Isabelle Riederer et al.
PLOS ONE (2010)
gamma delta T-cells: Potential regulators of the post-burn inflammatory response
Martin G. Schwacha
BURNS (2009)
Inflammation and Chronic Oxidative Stress in Radiation-Induced Late Normal Tissue Injury: Therapeutic Implications
Weiling Zhao et al.
CURRENT MEDICINAL CHEMISTRY (2009)
γδ T Cells and the Lymphoid Stress-Surveillance Response
Adrian C. Hayday
IMMUNITY (2009)
gamma delta T cells as immune effectors against high-grade gliomas
Lawrence S. Lamb
IMMUNOLOGIC RESEARCH (2009)
Proteasome Regulation of ULBP1 Transcription
James E. Butler et al.
JOURNAL OF IMMUNOLOGY (2009)
Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate
A. Poggi et al.
LEUKEMIA (2009)
Characterization and immunotherapeutic potential of γδ T-cells in patients with glioblastoma
Nichole L. Bryant et al.
NEURO-ONCOLOGY (2009)
Histone deacetylase inhibitors sensitize tumour cells for cytotoxic effects of natural killer cells
Mareike Schmudde et al.
CANCER LETTERS (2008)
Aging-dependent changes UN the radiation response of the adult rat brain
Matthew K. Schindler et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis
Andreas Rohner et al.
LEUKEMIA RESEARCH (2007)
Human γδ T cells -: Candidates for the development of immunotherapeutic strategies
Susann Beetz et al.
IMMUNOLOGIC RESEARCH (2007)
Perspectives of gamma delta T cells in tumor immunology
Dieter Kabelitz et al.
CANCER RESEARCH (2007)
Increase of NKAG2D ligands and sensitivity to NK cell-mediated cytotoxicity of tumor cells by heat shock and ionizing radiation
Joo-Young Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2006)
The role of the NKG2D receptor for tumor immunity
Jerome D. Coudert et al.
SEMINARS IN CANCER BIOLOGY (2006)
High-LET radiation induces inflammation and persistent changes in markers of hippocampal neurogenesis
R Rola et al.
RADIATION RESEARCH (2005)
The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
S Gasser et al.
NATURE (2005)
Early activation of γδ T lymphocytes in patients with severe systemic inflammatory response syndrome
A Matsushima et al.
SHOCK (2004)
The biological basis of a comprehensive grading system for the adverse effects of cancer treatment
J Williams et al.
SEMINARS IN RADIATION ONCOLOGY (2003)
Immune modulation by ionizing radiation and its implications for cancer immunotherapy
EJ Friedman
CURRENT PHARMACEUTICAL DESIGN (2002)
Share Paper
